Tugba Yilmaz

WomenWhoCurie

@ RadOnc

[Tugba Yilmaz @yiltuug]

#DCIS may seem simple, but multidisciplinary care is key💫
DCIS in 2025: Multidisciplinary Perspectives on Management — a great year-end SIS webinar.
Thanks to @drtolgaozmen for moderation, @CShahMD for the #RadOnc perspective, and all panelists for an excellent discussion. #SIS

[Tugba Yilmaz @yiltuug]

Got an email today from a #medstudent asking about my 2015 #IFMSA exchange program in #Taiwan 🇹🇼—instant flashbacks and so many great memories 🍜✨ Grateful for the journey and happy to be a small light for #futuredocs 👩‍⚕️👨‍⚕️
https://t.co/fRfAO9KgS3

[Tugba Yilmaz @yiltuug]

💫Every person leaves a footprint—light or dark🌝🌚 What matters is choosing your own way forward🌎

[Mind Matter @MindMatter28]

A young student once asked a wise Monk.... MUST READ.. 🧵

[Tugba Yilmaz @yiltuug]

🌟 Happy Radiation Oncologists Day!
Huge thanks to @troddernegi for this wonderful day! ☢️ Great to celebrate alongside our society head @banu_atalar, colleagues, and our patients. 💙✨#25thnovember #radonc

[Tugba Yilmaz @yiltuug]

Who said hazardous signs can’t be cute? 😅
I was gifted these tiny, radiation-signed knitted #keychains — soft, squishy, and a little #radioactive-chic.
Who knew safety symbols could be this adorable? 😌💛☢️🧶 #radonc

[Tugba Yilmaz @yiltuug]

A fruitful 3 days in Istanbul at #EXIOME2025, proudly endorsed by @troddernegi.
Honored to deliver an oral presentation, reconnect with a friend @adelapoite I met at last year’s ASTRO, and exchange ideas with amazing colleagues. Grateful and inspired after a successful conference

[Dr Rishabh Jain @DrRishabhOnco]

🧠 You can shrink the tumour—but not the tumour bed.
New RAPIDO analysis in BJS 2025 shows why small margins after TNT can turn dangerous 👇

💡 Trial: RAPIDO (n = 920, LARC)
🎯 TNT = 5×5 Gy + 6 CAPOX / 9 FOLFOX → TME
vs CRT = 25–28×1.8–2 Gy + capecitabine → TME

📊 8-year results:
• LRR 10.8% (TNT) vs 5.8% (CRT) → HR 1.91
• Spike seen only after sphincter-preserving surgery (SPS)
 → 12.1% (TNT) vs 4.8% (CRT) (HR 2.6)
• 🚨 If distal margin ≤ 10 mm → 25.4% (TNT) vs 1.8% (CRT) 💥 (HR 15.5)

🔍 Why?
TNT causes tumour shrinkage but leaves scattered viable cells in the original tumour bed.
✂️ Cutting “too close” (<1 cm) may slice through microscopic disease → higher local recurrence.

🇸🇪🇳🇱 Geography tells the story:
Sweden = more APR → no difference
Netherlands = more SPS & tight margins → higher TNT LRR

🩻 Takeaway:
TNT reduces distant mets ✅ but may raise local relapse if DRM ≤ 1 cm ⚠️
➡️ Surgeons must factor in baseline tumour bed, not just post-TNT shrinkage.

📖 Prata I et al. Br J Surg 2025
🔗 https://t.co/MqeM0xqH8i

#OncoTwitter #ColorectalCancer #RectalCancer #RadOnc #Surgery
@OncoAlert @esmo_open @BJSurgery
@myESMO

[BJS @BJSurgery]

Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial
➡️ https://t.co/ydSPMHlSWo

The difference in LRR between TNT and CRT mainly occurred in patients treated with sphincter-preserving surgery
Baseline information on the original tumour bed should be considered when determining the surgical approach after total neoadjuvant treatment

Work by Ilaria Prata, Max D Tanaka, Bengt Glimelius, Iris D Nagtegaal, Regina G H Beets-Tan, Lennart K Blomqvist, Alice M Couwenberg, Boudewijn van Etten, Geke A P Hospers, Elma Meershoek-Klein Kranenbarg, Koen C M J Peeters, Hein Putter, Annet G H Roodvoets, Cornelis J H van de Velde, Per J Nilsson, Corrie A M Marijnen

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @des_winter @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology
#Some4COLoprocto

[Tugba Yilmaz @yiltuug]

For a better future, we need truth—not just in science, but in all parts of life 🌎☢️

[Dr. Catharine Young @DrCatharineY]

Science is not a contest to be won.
It’s a collective pursuit of truth that evolves with evidence - not a debate settled by opinion or the loudest voice.

[Tugba Yilmaz @yiltuug]

✨ Excited to join #ASTRO2025 virtually this year from the comfort of home! While enjoying the #PRO session, I’m honored to see my photo featured in the International Offerings section from last year’s International Breakfast 🌍💫
#RadOnc #ASTRO25 @ASTRO_org #GlobalOncology

[Simon Lo @SimonLo21054188]

Celebrating World Radiotherapy Awareness Day- It’s an honour to be a radiation oncologist curing and controlling cancer and alleviate symptoms from cancer; radiotherapy is a very powerful tool in the armamentarium against cancer! @sandraturner49 @lucindamorris23

[David Palma, MD, PhD @drdavidpalma]

Interesting case report in the Green Journal showing lung function changes after SBRT - you can see how the contralateral lung compensates.

A similar effect was shown for locally advanced disease previously by Grace Parraga's team.
#sparetheotherlung

[Tugba Yilmaz @yiltuug]

Purrfect Shrinkage, Adaptive CaT Scan—radiating love and science into the weekday! 🌟 Because every paw-sitive step counts in the fight against cancer. 🐾 #RadiationForACure #radonc #RadiatePositivity #LungCancerAwareness #tb
#caturday #petthecat

[Tugba Yilmaz @yiltuug]

First cases, first outcomes as a new attending!
What makes you happier than prescribing your own dose? Definitely happy, healthy patients ☢️
✔️ #CRT 🫁
✔️Salvage prostate bed #RT 🧍‍♂️
Both patients are doing well! Grateful and excited for what's ahead!
#radonc #newattending

[Banu Atalar @banu_atalar]

Happy to share that we successfully hosted the very 1st Best of ESTRO in Turkiye, bringing together 150 RO pros for an inspiring day of cutting-edge science.
Thanks to our Turkish ROs whose hard work made this possible—and to @ESTRO for launching this initiative. @troddernegi

[ESTRO @ESTRO_RT]

📢 On #WomenInScience Day, ESTRO celebrates the incredible women shaping radiotherapy &amp; oncology! 💡✨ With 70+ inspiring photos from institutes worldwide, we highlight their impact &amp; the need for diversity in STEM.

🌍 Read more: https://t.co/XWDxHoAWfG

#GirlsInScience #Radonc

[OhioStateRadOnc @OhioStateRadOnc]

We had the pleasure of hosting a newly graduated Radiation Oncologist from Turkey join our International Training Center for the past month! We’re excited for Dr. Yilmaz and her new journey and are thankful she chose #OSU for additional training! 🥼♥️🎉🩶

[Tugba Yilmaz @yiltuug]

My first product of ceramic workshop as a #radonc #womenwhocurie ☢️🌵